adventitious agents

0:14:53

A sensitive sample preparation pipeline for adventitious virus detection using nanopore sequencing

0:08:47

Safety Evaluation & Toxicology ASR Review Video 2022

0:53:46

Validating and implementing nucleic acid testing-based methods for mycoplasma detection

1:07:14

VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS

0:02:21

Inside the KappaMab manufacturing process

0:02:11

Viral vector production series: Keeping up with regulatory demands

0:20:19

15-minute Webcast: Assessing Viral Clearance in Early Phase Process Development

0:56:46

[Quality] ICH Q5A

0:45:06

Fermentative production of enzymes-amylase and protease

0:00:21

Seed Germination Stage 1 vs Stage 7

0:18:06

Serge Ohreser| Merck Millipore | France | Vaccines 2014 | OMICS International

0:04:15

Step 8: How to do IND Life Cycle Management? | Regulatory Learnings| DRA

0:02:56

Introduction to Viral Safety Part 1 - Two Minute Tuesday Technical Training

0:01:14

Risk factors in the development of stem cell therapy | RTCL.TV

0:01:09

Risk factors in the development of stem cell therapy | RTCL.TV

0:03:44

ABRF2024: Optimizing Core Communication and Collaboration with Veterinary Staff

0:17:53

1.5. Генная терапия: формуляция, валидация производства, стабильность, посторонние агенты

1:05:15

Cell and Gene Therapy Solutions: Enabling PSC Translation Workflows

0:02:15

Step 6: How does USFDA review an Investigational New Drug (IND) application? | Regulatory Learnings

0:15:24

Drug Device Combination Products | Episode 01- What are the Regulations for Combination Products?

0:04:42

Step 7: How are Clinical Trials Registered in USA? | Regulatory Learnings

0:24:37

Episode 27: MicroQuant™- Modernizing Quality Control Testing

0:05:30

Orphan Drug Development | Episode 07 - How to get Orphan Drug Designation in Japan | MHLW | DRA

0:05:30

What is Investigational New Drug (IND) Application? | Regulatory Learnings | Drug Regulatory Affairs